Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis

Daniel J No; Mina Amin; Alexander Egeberg; Jacob P Thyssen; Jashin J Wu

doi:10.1080/09546634.2017.1341606

Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis

Daniel J No, Mina Amin, Alexander Egeberg, Jacob P Thyssen, Jashin J Wu

Department of Clinical Medicine

1 Citation (Scopus)

Abstract

Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.

Original language	English
Journal	Journal of Dermatological Treatment
Volume	29
Issue number	1
Pages (from-to)	100-101
ISSN	0954-6634
DOIs	https://doi.org/10.1080/09546634.2017.1341606
Publication status	Published - 2 Jan 2018

Keywords

Antibodies, Monoclonal/therapeutic use
Clinical Trials as Topic
Dermatitis, Atopic/drug therapy
Etanercept/therapeutic use
Humans
Interleukin-13/metabolism
Interleukin-4/metabolism
Psoriasis/drug therapy
Severity of Illness Index
Skin/metabolism
Up-Regulation

Access to Document

10.1080/09546634.2017.1341606

Cite this

@article{c3d617a05b7a4fe89cd959c32d3d5e8f,

title = "Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis",

abstract = "Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.",

keywords = "Antibodies, Monoclonal/therapeutic use, Clinical Trials as Topic, Dermatitis, Atopic/drug therapy, Etanercept/therapeutic use, Humans, Interleukin-13/metabolism, Interleukin-4/metabolism, Psoriasis/drug therapy, Severity of Illness Index, Skin/metabolism, Up-Regulation",

author = "No, {Daniel J} and Mina Amin and Alexander Egeberg and Thyssen, {Jacob P} and Wu, {Jashin J}",

year = "2018",

month = jan,

day = "2",

doi = "10.1080/09546634.2017.1341606",

language = "English",

volume = "29",

pages = "100--101",

journal = "Journal of Dermatological Treatment",

issn = "0954-6634",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - Atopic dermatitis 2017

T2 - where we were 10-15 years ago in psoriasis

AU - No, Daniel J

AU - Amin, Mina

AU - Egeberg, Alexander

AU - Thyssen, Jacob P

AU - Wu, Jashin J

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.

AB - Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.

KW - Antibodies, Monoclonal/therapeutic use

KW - Clinical Trials as Topic

KW - Dermatitis, Atopic/drug therapy

KW - Etanercept/therapeutic use

KW - Humans

KW - Interleukin-13/metabolism

KW - Interleukin-4/metabolism

KW - Psoriasis/drug therapy

KW - Severity of Illness Index

KW - Skin/metabolism

KW - Up-Regulation

U2 - 10.1080/09546634.2017.1341606

DO - 10.1080/09546634.2017.1341606

M3 - Comment/debate

C2 - 28604121

SN - 0954-6634

VL - 29

SP - 100

EP - 101

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

IS - 1

ER -

Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis

Abstract

Keywords

Access to Document

Fingerprint

Cite this